Drugs
Werse, B., Kamphausen, G., Søgaard, T. F., Bear, D., Audran, M., Wilkins, C., Potter, G., Fortin, D., Hakkarainen, P., Faria, R., Quintas, J., Grigg, J., Jauffret-Roustide, M., & Barratt, M. J. (2024). Impact of the COVID-19 pandemic on cannabis cultivation and use in 18 countries. International Journal of Drug Policy, 104652. https://doi.org/10.1016/j.drugpo.2024.104652 A644
Lenton, S., Potter, G., Fortin, D., Granville, A., Grigg, J., Sevigny, E., Wilkins, C., Decorte, T., & Barratt, M. (2024). Growing practices and the use of potentially harmful chemical additives from a web survey of mainly small-scale cannabis growers in 18 countries. International Journal of Drug Policy, 104662. https://doi.org/10.1016/j.drugpo.2024.104662 A643
Wilkins, C., Romeo, J., Rychert, M., & Graydon-Guy, T. (2024). Exploring the substitution of cannabis for alcohol and other drugs among a large convenience sample of people who use cannabis. Harm Reduction Journal, 21(1), 192. doi:10.1186/s12954-024-01111-w A638
Rychert, M., & Wilkins, C. (2024). Implementation of the Medicinal Cannabis Scheme in New Zealand: six emerging trends. New Zealand Medical Journal, 137(1604), 73-86. doi:10.26635/6965.6666 A637
Søgaard, T. F., Brummer, J. E., Wilkins, C., Sznitman, S. R., Sevigny, E. L., Frank, V. A., Potter, G., Hakkarainen, P., Barratt, M. J., Werse, B., Grigg, J., Fortin, D., Bear, D., Lenton, S., Jauffret-Roustide, M., & Kirtadze, I. (2024). Global patterns in small-scale cannabis growers’ distribution practices: Exploring the grower-distributor nexus. International Journal of Drug Policy, Available online 3 June, 104463. https://doi.org/10.1016/j.drugpo.2024.104463 A629
Rychert, M., Sultan, A., & Mialon, M. (2024). Editorial: AI and new digital technologies have transformed alcohol and other drug industries lobbying. Drugs, Habits and Social Policy, 25(1), 1-5. doi:10.1108/DHS-05-2024-072 A623
Lyons, A., Moewaka Barnes, A., Goodwin, I., Carah, N., Young, J., Spicer, J., & McCreanor, T. (2024). Exposure to digital vape marketing among young people in Aotearoa New Zealand. New Zealand Medical Journal, 137(1589), 20–38. https://doi.org/10.26635/6965.6317 A621
Sevigny, E. L., Potter, G., Wilkins, C., Barratt, M. J., Søgaard, T. F., Hakkarainen, P., Grigg, J., & Roustide, M. J. (2023). Conflict and social control among cannabis growers. International Journal of Drug Policy, published online Dec 15, 104292, https://doi.org/10.1016/j.drugpo.2023.104292
Rychert, M., & Wilkins, C. (2023). Referendum Campaigns in Hybrid Media Systems: Insights From the New Zealand Cannabis Legalisation Referendum. Media and Communication, 11(1), 56-68. https://doi.org/10.17645/mac.v11i1.6021 A615
van der Sanden, R., Wilkins, C., Rychert, M., & Barratt, M. J. (2023). Social Supply and the Potential for Harm Reduction in Social Media Drug Markets. Contemporary Drug Problems, 50(3), 381-401. https://doi.org/10.1177/00914509231178940 A614
D'Mello, K., Chan, G. C. K., Hall, W., Rychert, M., Wilkins, C., & Hammond, D. (2023). Use of flavored cannabis vaping products in the US, Canada, Australia, and New Zealand: findings from the international cannabis policy study wave 4 (2021). American Journal of Drug and Alcohol Abuse, 1-12. https://doi.org/10.1080/00952990.2023.2238116 A613
Belackova, V., Rychert, M., Wilkins, C., & Pardal, M. (2023). Cannabis Social Clubs in Contemporary Legalization Reforms: Talking Consumption Sites and Social Justice. Clinical Therapeutics, 45(6), 551-559. https://doi.org/10.1016/j.clinthera.2023.03.017 A609
Withanarachchie, V., Rychert, M., & Wilkins, C. (2023). Barriers and facilitators to prescribing medicinal cannabis in New Zealand Journal of Primary Health Care, 15(2), 135–146. https://doi.org/10.1071/HC22122 A607
Crossin, R., Cleland, L., Wilkins, C., Rychert, M., Adamson, S., Potiki, T., Pomerleau, A. C., MacDonald, B., Faletanoai, D., Hutton, F., Noller, G., Lambie, I., Sheridan, J. L., George, J., Mercier, K., Maynard, K., Leonard, L., Walsh, P., Ponton, R., . . . Boden, J. (2023). The New Zealand drug harms ranking study: A multi-criteria decision analysis. Journal of Psychopharmacology. https://doi.org/10.1177/02698811231182012 A602
Rychert, M., Romeo, J. S., & Wilkins, C. (2023). Exploring Differences in Daily Vaping of Nicotine and Cannabis among People Who Use Drugs in New Zealand. Substance Use & Misuse, 58(11), 1388-1398. https://doi.org/10.1080/10826084.2023.2223276 A601
van der Sanden, R., Wilkins, C., & Rychert, M. (2023). “I straight up criminalized myself on messenger”: law enforcement risk management among people who buy and sell drugs on social media. Drugs: Education, Prevention and Policy, published online June 20. https://doi.org/10.1080/09687637.2023.2224497 A600
Wadsworth, E., Rynard, V., Driezen, P., Freeman, T. P., Rychert, M., Wilkins, C., Hall, W., Gabrys, R., & Hammond, D. (2023). Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019-2021: a repeat cross-sectional study. Harm Reduction Journal, 20(1), 19. https://doi.org/10.1186/s12954-023-00753-6 A599
Withanarachchie, V., Rychert, M., & Wilkins, C. (2023). The role of cannabis clinics in the health system: a qualitative study of physicians' views in New Zealand. BMC Health Services Research, 23(10, 2023), https://doi.org/10.1186/s12913-12022-09021-y. A592
van der Sanden, R., Wilkins, C., Rychert, M., & Barratt, M. J. (2022). 'Choice' of social media platform or encrypted messaging app to buy and sell illegal drugs. International Journal of Drug Policy, 108, 103819, doi:10.1016/j.drugpo.2022.103819 A590
van der Sanden, R., Wilkins, C., Rychert, M., & Barratt, M. J. (2022). The Use of Discord Servers to Buy and Sell Drugs. Contemporary Drug Problems, 49(4), 453-477, doi:10.1177/00914509221095279 A589
Sanchez Lozano, C. D., Wilkins, C., Rychert, M. (2022). Exploring the Adjudication of Methamphetamine-related Housing Contamination Cases in New Zealand. Journal of Law and Medicine, 29(1), 142-155. A568
Klein, A., Rychert, M., & Emanuel, M. A. (2022). Towards social justice and economic empowerment? Exploring Jamaica’s progress with implementing cannabis law reform. Third World Quarterly, 43(11), 2693-2711, doi:10.1080/01436597.2021.1989300 A591
Sanchez Lozano, C. D., Wilkins, C., & Rychert, M. (2022). Lessons from the implementation of residential methamphetamine contamination policies in New Zealand. Drug and Alcohol Review, published online Dec 26, doi:10.1111/dar.13593 A588
Sanchez Lozano, C. D., Wilkins, C., & Rychert, M. (2022). Outcomes from the New Zealand Tenancy Tribunal after a review of policy on residential housing methamphetamine contamination. Journal of the Royal Society of New Zealand, published online July 24, 1-15, doi:10.1080/03036758.2022.2103575 A587
Sanchez Lozano, C. D., Wilkins, C., & Rychert, M. (2022). Comparative analysis of policy responses to residential methamphetamine contamination by two public housing authorities in the United States and New Zealand. Drugs: Education, Prevention and Policy, published online May 15, 1-12, doi:10.1080/09687637.2022.2072188 A586
Rychert, M., Wilkins, C., van der Sanden, R., & Prasad, J. (2022). Exploring digital news, advocacy networks and social media campaigns ‘for’ and ‘against’ cannabis legalisation during New Zealand’s cannabis legalisation referendum. Drugs: Education, Prevention and Policy, published online June 29, 1-11, doi:10.1080/09687637.2022.2090897 A585
Wilkins, C., Rychert, M., Queirolo, R., Lenton, S. R., Kilmer, B., Fischer, B., Decorte, T., Hansen, P., Ombler, F. (2022). Assessing options for cannabis law reform: A Multi-Criteria Decision Analysis (MCDA) with stakeholders in New Zealand. International Journal of Drug Policy, 105, 103712. doi: 10.1016/j.drugpo.2022.103712. A583
Crossin, R., Boden, J. M., Wilkins, C., & Adamson, S. (2022). The New Zealand illicit drug harms index: How can it inform a health-based approach to drug use? New Zealand Medical Journal, 135, 8-10. https://www.ncbi.nlm.nih.gov/pubmed/35728179 A593
Crossin, R., Cleland, L., Rychert, M., Wilkins, C., & Boden, J. M. (2022). Measuring drug harm in New Zealand: A stocktake of current data sources. New Zealand Medical Journal, 135(1554), 93-104. https://www.ncbi.nlm.nih.gov/pubmed/35728221 A584
Wilkins, C., Tremewan, J., Rychert, M., Atkinson, Q., Fischer, G., Lavender Forsyth, A. (2022). Predictors of voter support for the legalization of recreational cannabis use and supply via a national referendum, International Journal of Drug Policy, 99, 103442. Open Access. https://doi.org/10.1016/j.drugpo.2021.103442 A548
Withanarachchie V, Rychert M, Wilkins C. (2022). Assessing progress with the implementation of the New Zealand Medicinal Cannabis Scheme [Editorial]. New Zealand Medical Journal, 135(1548):7-12. A569
van der Sanden, R., Wilkins, C., Romeo, J., Rychert ,M., Barratt M. (2021). Predictors of using social media to purchase drugs in New Zealand: Findings from a large-scale online survey. International Journal of Drug Policy, 98, 103430. doi: 10.1016/j.drugpo.2021.103430 A543
Adams, P., Rychert, M., Wilkins, C. (2021). How does the influence of the cannabis industry differ from that of alcohol and tobacco? [Response to Commentaries]. Addiction, in press.
Adams, PJ., Rychert, M., & Wilkins, C. (2021). Policy influence and the legalized cannabis industry: learnings from other addictive consumption industries. Addiction, published online 19 March, https://doi.org/10.1111/add.15483 A529
Price, M., Wilkins, C., Tscharke, B. J., Baker, T., Mueller, J. F., Trowsdale, S. (2021). Spatial, temporal and socioeconomic patterns of illicit drug use in New Zealand assessed using wastewater-based epidemiology timed to coincide with the census. New Zealand Medical Journal, 134(1537), 70-85. A530
Price, M., Wilkins, C., & Trowsdale, S. (2021). Comment on “Estimating Alcohol Consumption by Wastewater-Based Epidemiology: An Assessment of the Correction Factor for Ethyl Sulfate Using Large-Scale National Monitoring Data”. Environmental, Science & Technology Letters, 8(11), 1015-1016.
Trowsdale, S., Price, M., Wilkins, C., Tscharke, B., Mueller, J., Baker, T. (2021). Quantifying nicotine and alcohol consumption in New Zealand using wastewater-based epidemiology timed to coincide with census. [Article]. Drug and Alcohol Review, 40(7), 1178-1185. doi: 10.1111/dar.13268. A528
Rychert, M., Wilkins, C. (2021). Response to commentaries: The politics (and science) of cannabis law reform. Drug and Alcohol Review, published online 19 May. doi: 10.1111/dar.13312.
Rychert, M., Parker, K., Wilkins, C., Graydon-Guy, T. (2021). Predictors of medicinal cannabis users' willingness to utilise a new prescription Medicinal Cannabis Scheme in New Zealand. New Zealand Medical Journal, 134(1534), 66–75. A521
Rychert, M., Emanuel, M.A., Wilkins, C. (2021). Foreign investment in emerging legal medicinal cannabis markets: the Jamaica case study. Globalization and Health, 17(1), 38. A522
Rychert M, and Wilkins C. (2021). Why did New Zealand's referendum to legalise recreational cannabis fail? Drug and Alcohol Review, 40(6), 877-881. doi: 10.1111/dar.13268. A520
Wilkins, C., & Rychert, M. (2021). The rejection of cannabis legalization in New Zealand: Issues with the Cannabis Legalization and Control Bill or wider concerns? Addiction, 116(2), 236-238. doi: 210.1111/add.15361. A502
Rychert, M., Emanuel, M.A., Wilkins, C. (2020) Issues in the establishment of a therapeutic cannabis market under Jamaica's Dangerous Drugs Amendment Act 2015. International Journal of Drug Policy, 86, https://doi.org/10.1016/j.drugpo.2020.102945 A501
Wilkins, C., & Rychert, M. (2020). Assessing New Zealand’s Cannabis Legalisation and Control Bill: Prospects and Challenges. Addiction, 116(2), 222-230. https://doi.org/10.1111/add.15144 A500
Rychert, M., & Wilkins, C. (2020). “You have to make some money before you can do some good”: Balancing the commercial, social and public health objectives in a “community enterprise” regulatory model for alcohol and cannabis. International Journal of Drug Policy, 77, 102689. https://doi.org/10.1016/j.drugpo.2020.102689 A490
Wilkins, C., Romeo, J.S., Rychert, M., & Graydon-Guy, T. (2020). Determinants of the retail price of illegal drugs in New Zealand. International Journal of Drug Policy. Published online ahead of print April 10, doi: 10.1016/j.drugpo.2020.102728. A489
Sanchez Lozano, C. D., Wilkins, C., & Rychert, M. (2020) Investigating the New Zealand policy response to methamphetamine-contaminated houses. Drug Testing and Analysis, doi: 10.1002/dta.2782 A488
Rychert, M., Romeo, J. S., Wilkins, C., & Graydon-Guy, T. (2020). Could the community trust model be applied to regulate cannabis? Findings from a survey of two alcohol licensing trust communities in New Zealand. Drugs: Education, Prevention and Policy, 1-9. doi:10.1080/09687637.2019.1707776 A487
Rychert, M., Wilkins, C., Parker, K., Graydon-Guy, T. (2020). Exploring medicinal use of cannabis in a time of policy change in New Zealand. New Zealand Medical Journal, 22 May, 133, 54-69. A486
Wilkins, C., Rychert, M. (2020). The Government’s proposal to legalise cannabis in New Zealand: 10 key questions [Editorial]. New Zealand Medical Journal, 22 May, 133, 9-15. A485
Rychert, M., Wilkins, C., & Noller, G. (2019). Medicinal Cannabis Scheme in New Zealand: lessons from international experience and our own recent drug policy reform setbacks. New Zealand Medical Journal, 132(1503), 8-12. A482
Rychert, M., & Wilkins, C. (2019). A 'community enterprise' model for recreational cannabis: Lessons from Alcohol Licensing Trusts in New Zealand. International Journal of Drug Policy, 67, 72-78. doi: 10.1016/j.drugpo.2019.03.007. A477
Rychert, M., & Wilkins, C. (2019). New Zealand's review of the Psychoactive Substances Act 2013: a missed learning opportunity ahead of the national cannabis law reform referendum? Addiction, 114(6), 1129-1130. 10.1111/add.14589. A476
Rychert, M., & Wilkins, C. (2018). Understanding the development of a regulated market approach to new psychoactive substances (NPS) in New Zealand using Punctuated Equilibrium Theory. Addiction, 113(11), 2132-2139. A457
Wilkins, C., Rychert, M., Romeo, J., & Randerson, S. (2019). Smoke in our eyes: the Sense Partners’ evaluation of the legalisation of cannabis in New Zealand [Editorial]. New Zealand Medical Journal, 132(1490), 6-9. https://www.nzma.org.nz/journal/read-the-journal/all-issues/2010-2019/2019/vol-2132-no-1490-2022-february-2019/7811. A456
Wilkins, C., Romeo, J., Rychert, M., Prasad, J., & Graydon-Guy, T. (2018). Determinants of high availability of methamphetamine, cannabis, LSD and ecstasy in New Zealand: Are drug dealers promoting methamphetamine rather than cannabis? International Journal of Drug Policy, 61, 15-22. doi: 10.1016/j.drugpo.2018.09.007. A455
Wilkins, C., Lai, F.-Y., O’Brien, J., Thai, P., & Mueller, J. (2018). Comparing methamphetamine, MDMA, cocaine, codeine and methadone use between the Auckland region and four Australian states using wastewater-based epidemiology (WBE). New Zealand Medical Journal, 131(1478), 12-20. A446
Wilkins, C., Sznitman, S., Decorte, T., Hakkarainen, P., & Lenton, S. (2018). Characteristics of cannabis cultivation in New Zealand and Israel. Drugs and Alcohol Today, 18(2), 90-98. A442
Belackova, V., & Wilkins, C. (2017). Consumer agency in cannabis supply – exploring auto-regulatory documents of the cannabis social clubs in Spain. International Journal of Drug Policy, 54, 26-34. A428
Rychert, M., & Wilkins, C. (2018). A critical analysis of the implementation of a legal regulated market for new psychoactive substances ("legal highs") in New Zealand. International Journal of Drug Policy, 55, 88-94. A425
Wilkins, C. (2018). A “not-for-profit” regulatory model for legal recreational cannabis: Insights from the regulation of gaming machine gambling in New Zealand. International Journal of Drug Policy, 53, 115-122. A415
Rychert, M., Wilkins, C., Parker, K., & Witten, K. (2017). Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand. Drug and Alcohol Review, published online Dec 29, doi: 10.1111/dar.12655. A416
Hakkarainen, P., Decorte, T., Sznitman, S., Karjalainen, K., Barratt, M., Frank, V., Lenton, S., Potter, G., Werse, B., Wilkins, C. (2017). Examining the blurred boundaries between medical and recreational cannabis: Results from an international study of small-scale cannabis cultivation. Drugs: Education, Prevention, and Policy, published online 18 December, https://doi.org/10.1080/09687637.09682017.01411888
«Rychert, M., Wilkins, C., & Witten, K. (2017). Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances (NPS) (‘legal highs’) in New Zealand. Drug and Alcohol Review, published online 27 Feb, doi: 10.1111/dar.12467 [Abstract]. A405
«Lai, F., Wilkins, C., Thai, P., & Mueller, J. (2017). An exploratory wastewater analysis study of drug use in Auckland, New Zealand. Drug and Alcohol Review, published online 12 March, doi: 10.1111/dar.12509 [Abstract]. A404
«Rychert, M., Wilkins, C., Witten, K. (2017). “Lost in translation”: issues with the establishment of a legal market for ‘low risk’ psychoactive products (‘legal highs’) in New Zealand. Drugs: Education, Prevention & Policy, Published online: 02 Feb, doi: 10.1080/09687637.09682017.01282422. A401
«Wilkins, C., & Rychert, M. (2017). Recent developments with the New Zealand regulated market approach to 'low risk' psychoactive products. Addiction, 112, 32-39. doi: 10.1111/add.13495. A396
«Rychert, M., & Wilkins, C. (2016). Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, ‘legal highs’) in New Zealand. International Journal of Drug Policy, 37, 90-97. A402
«Wilkins, C., Parker, K., Prasad, J., Jawalkar, S. (2016). Do police arrestees substitute legal highs for other drugs? International Journal of Drug Policy, 31, 74-79. A400
«Wilkins, C. (2016). The case for medicinal cannabis: where there is smoke there may well be fire [Editorial]. New Zealand Medical Journal, 129, 11-14. A399
«Rychert, M., & Wilkins, C. (2016). What products are considered psychoactive under New Zealand’s regulated legal market for new psychoactive substances (NPS, ‘legal highs’)? Implications for law enforcement and penalties. Drug Testing and Analysis, doi: 10.1002/dta.1943. A385
«Wilkins, C., Prasad, J., Wong, K., Rychert, M., & Graydon Guy, T. (2016). An exploratory study of the health harms and utilisation of health services of frequent legal high users under an interim regulated legal high market in central Auckland New Zealand Medical Journal, 129(1431), 51-58. A384
«Wilkins, C. (2016). After the legalisation of cannabis: the Cannabis Incorporated Society (CIS) regulatory model for recreational cannabis in New Zealand [Viewpoint]. New Zealand Medical Journal, 129(1433), 17-20. A378
«Barratt, M., Potter, G., Wouters, M., Wilkins, C., Werse, B., Perälä, J., Mulbjerg Pedersen, M., Nguyen, H., Malm, A., Lenton, S., Dirk Korf, D., Klein, A., Heyde, J., Hakkarainen, P., Asmussen Frank, V., Decorte, T., Bouchard, M., & Blok, T. (2015). Lessons from conducting trans-national Internet-mediated participatory research with hidden populations of cannabis cultivators. International Journal of Drug Policy, 26(3), 238-249. doi:10.1016/j.drugpo.2014.12.004. A371
«Wilkins, C. (2014). The interim regulated legal market for NPS (‘legal high’) products in New Zealand: The impact of new retail restrictions and product licensing. Drug Testing and Analysis, Article first published online 12 May, DOI: 10.1002/dta.1643. A347
«Wilkins, C., Sheridan, J., Adams, P., Russell, B., Ram, S., & Newcombe, D. (2013). The new psychoactive substances regime in New Zealand: A different approach to regulation. Journal of Psychopharmacology, first published on June 5, 2013, doi:10.1177/0269881113491441. A325
«Wilkins, C., & Sweetsur, P. (2013). The impact of the prohibition of BZP legal highs on the prevalence of BZP, new legal highs and other drug use in New Zealand. Drug and Alcohol Dependence, 127, 72-80. A323
«Wilkins, C., & Sweetsur, P. (2012). Criminal justice outcomes for cannabis use offences in New Zealand, 1991–2008. International Journal of Drug Policy, 23(6), 505-511. A305
«Wilkins, C. (2011). A paradigm shift in recreational drug use: the challenge of legal highs in New Zealand [Letter]. New Zealand Medical Journal, 124(1339), 99-101. A285
«Wilkins, C., Sweetsur, P., & Griffiths, R. (2011). Recent trends in pharmaceutical drug use among frequent injecting drug users, frequent methamphetamine users and frequent ecstasy users in New Zealand, 2006–2009. Drug and Alcohol Review, 30, 255-263. A276
«Wilkins, C., & Sweetsur, P. (2011). The association between spending on methamphetamine and cannabis for personal use and earnings from acquisitive crime among police detainees in New Zealand. Addiction, 106, 789–797. A272
«Wilkins, C., & Sweetsur, P. (2011). The association between the number of days of methamphetamine use and the level of earnings from acquisitive crime among police detainees in New Zealand. Bulletin on Narcotics, Volume LX, 2008, 59-77. A271
«Bouchard, M., & Wilkins, C. (2010). Illegal markets and the economics of organized crime. In M. Bouchard & C. Wilkins (Eds.), Illegal Markets and the Economics of Organized Crime (pp. 1-4). London: Routledge. SB51
«Wilkins, C., & Sweetsur, P. (2010). Differences in harm from legal BZP/TFMPP party pills between North Island and South Island users in New Zealand: A case of effective industry self regulation? International Journal of Drug Policy, 21, 86-90. A246
«Wilkins, C., & Sheridan, J. (2010). The ‘P’ problem in New Zealand. In R. Pates & D. Riley (Eds.), Interventions for Amphetamine Misuse (pp. 129-147). West Sussex, UK: Blackwell Publishing. SB49
«Bouchard, M., & Wilkins, C. (2009). Illegal markets and the economics of organized crime. Global Crime, 10(1-2), 1-5. A235
«Wilkins, C., & Sweetsur, P. (2008). Tracking the Availability of Drugs in New Zealand: Implications for Policy Response. Social Policy Journal of New Zealand, 34, 163-171. A234
«Wilkins, C., Sweetsur, P., & Girling, M. (2008). Patterns of benzylpiperazine/ trifluoromethylphenylpiperazine (BZP/TFMPP) party pill use and adverse effects in a population sample in New Zealand. Drug and Alcohol Review, 27, 633-639. A224
«Wilkins, C., & Sweetsur, P. (2008). Trends in population drug use in New Zealand: Findings from national household surveying of drug use in 1998, 2001, 2003 and 2006. New Zealand Medical Journal, 121, 61-71. A216
«Wilkins, C., Girling, M., & Sweetsur, P. (2007). The prevalence of use, dependency and harms of legal ‘party pills’ containing benzylpiperazine (BZP) and trifluorophenylmethylpiperazine (TFMPP) in New Zealand. Journal of Substance Use, 12, 213-. A210
«Wilkins, C., & Sweetsur, P. (2007). Individual dollar expenditure and earnings from cannabis in New Zealand. International Journal of Drug Policy, 18, 187-193. A200
«Sheridan, J., Butler, R., Wilkins, C., & Russell, B. (2007). Legal piperazine-containing party pills – a new trend in substance misuse. Drug and Alcohol Review, 26, 335-343. A199
«Wilkins, C., Sweetsur, P., & Casswell, S. (2006). Recent population trends in amphetamine use in New Zealand: Comparisons of findings from national household drug surveying in 1998, 2001 and 2003. New Zealand Medical Journal, 119(1244), http://www.nzma.org.nz/journal/119-1244/2285/. A190
«Wilkins, C., & Sweetsur, P. (2006). Exploring the structure of the illegal market for cannabis in New Zealand. De Economist, 154(4), DOI 10.1007/s10645-10006-19029-10647. A189
«Wilkins, C., Reilly, J., Rose, E., & Casswell, S. (2005). Characteristics of amphetamine-type stimulants (ATS) use in New Zealand: informing policy responses. Social Policy Journal of New Zealand, 25, 142-153. A170
«Wilkins, C., Reilly, J., Pledger, M., & Casswell, S. (2005). Estimating the dollar value of the illicit market for cannabis in New Zealand. Drug and Alcohol Review, 24(3), 227-234. A169
«Wilkins, C., Reilly, J., & Casswell, S. (2005). Cannabis 'tinny' houses in New Zealand; implications for the use of cannabis and other drugs in New Zealand. Addiction, 100, 971-980. A168
«Wilkins, C., & Casswell, S. (2003). Organised crime in cannabis cultivation in New Zealand: an economic analysis. Contemporary Drug Problems, 30, 757-777. A157
«Wilkins, C., Pledger, M., Bhatta, K., & Casswell, S. (2004). Patterns of amphetamine use in New Zealand: findings from the 2001 National Drug Survey. New Zealand Medical Journal, 117(1190), 796-. A155
«Wilkins, C., Bhatta, K., Pledger, M., & Casswell, S. (2003). Ecstasy use in New Zealand: findings from the 1998 and 2001 National Drug Surveys. New Zealand Medical Journal, 116, 383-393. A147
«Wilkins, C. (2002). Designer amphetamines in New Zealand: challenges and policy initiatives. Social Policy Journal of New Zealand, 19, 14-27. A150
«Wilkins, C., Bhatta, K., & Casswell, S. (2002). The effectiveness of cannabis crop eradication operations in New Zealand. Drug and Alcohol Review, 21, 369-374. A143
«Wilkins, C., Bhatta, K., & Casswell, S. (2002). The emergence of amphetamine use in New Zealand: findings from the 1998 and 2001 national drug surveys. New Zealand Medical Journal, 115(1166), 256-263. A142
«Wilkins, C., Casswell, S., Bhatta, K., & Pledger, M. (2002). Drug Use in New Zealand: National Surveys Comparison 1998 & 2001. Auckland: Alcohol & Public Health Research Unit. C18
«Wilkins, C., & Casswell, S. (2002). The cannabis black market and the case for the legalisation of cannabis in New Zealand. Social Policy Journal of New Zealand, 18, 31-43. A139
«Wilkins, C., Bhatta, K., & Casswell, S. (2002). A demand side estimate of the financial turnover of the cannabis black market in New Zealand. Drug and Alcohol Review, 21, 145-151. A137
«Wilkins, C. (2001). A 'New Institutional Economic' approach to the reliability of street-level transactions. Contemporary Drug Problems, 28, 679-693. A136
Wilkins, C. (2001). Cannabis transactions and law reform. Agenda, 8(4), 321-331. A132
«Field, A., & Casswell, S. (2001). Marijuana use in New Zealand, 1990 and 1998. New Zealand Medical Journal, 114, 355-358. A130
«Wilkins, C. (2001). Cannabis transactions and law reform. Agenda, 8(4), 321-331. A128
«Field, A., & Casswell, S. (2000). Perspectives on marijuana policy in New Zealand: 1990 and 1998. Social Policy Journal of New Zealand, 14, 104-113. A124
«Field, A., & Casswell, S. (2000). Options for cannabis policy in New Zealand. Social Policy Journal of New Zealand, 14(14), 49-64. A123
Dacey, B., & Moewaka Barnes, H. (2000). Te Ao Taru Kino: Drug Use Among Maori, 1998. University of Auckland: Whariki Maori Health Research Unit, Alcohol and Public Health Research Unit. C17
Field, A., & Casswell, S. (1999). Drug Use in New Zealand: Comparison Surveys 1990 & 1998. University of Auckland: Alcohol and Public Health Research Unit. C16
Field, A., & Casswell, S. (1999). Drugs in New Zealand: A National Survey 1998. University of Auckland: Alcohol and Public Health Research Unit. C15
«Abel, S., & Casswell, S. (1998). Cannabis policy: issues and options. New Zealand Medical Journal, 111(25 September 1998), 367-370. A105
«Abel, S., & Casswell, S. (1998). Cannabis in Schools: Issues for Principals and Boards. New Zealand Journal of Educational Studies, 33(1), 55-66. A104
«Abel, S., & Casswell, S. (1998). Cannabis in New Zealand: Policy and prospects. Social Policy Journal of New Zealand, 10, 70-85. A98
Abel, S. (1997). Cannabis and Schools: Boards of Trustees' Responses. Auckland: Alcohol & Public Health Research Unit. D146
Abel, S. (1997). Cannabis and Schools: Boards of Trustees' Responses, August. Auckland: Alcohol & Public Health Research Unit. D145
«Casswell, S. (1997). How do we respond to recreational drug use in the Southern Hemisphere? [Editorial]. Drug and Alcohol Review, 16, 381-382. A92
«Abel, S. (1997). Cannabis policy in Australia and New Zealand. Drug and Alcohol Review, 16, 421-428. A90
Abel, S., & Casswell, S. (1993). Cannabis Policy in New Zealand: A Background Paper. Auckland: Alcohol & Public Health Research Unit. D69
«Black, S., & Casswell, S. (1993). Recreational drug use in New Zealand. Drug and Alcohol Review, 12, 37-48. A54
Black, S., & Casswell, S. (1993). Drugs in New Zealand: A Survey 1990. University of Auckland: Alcohol & Public Health Research Unit. C6
«Casswell, S. (1992). Alcohol and other recreational drug issues in New Zealand. Journal of Drug Issues, 22(3), 797-805. A48
Abel, S., Wyllie, A., & Casswell, S. (1992). The primary prevention of alcohol and other drug-related problems amongst women: a literature review. Auckland: Alcohol & Public Health Research Unit, University of Auckland. D60
«Black, S., & Casswell, S. (1992). User reports of problems associated with alcohol and marijuana use. British Journal of Addiction, 87, 1275-1280. A44
